AnGes, Inc.
AMGXFOTCHealthcare● Active
$0.36
+$0.00(+0.00%)
Market Cap$142504592
P/E Ratio—
52W High$0.3602
52W Low$0.3353
AnGes, Inc.（AMGXF）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · AMGXF · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($5.13B) | ($27.64B) | ($7.47B) | ($14.71B) | ($13.74B) |
| Depreciation & Amort. | $0.05B | $3.37B | $3.11B | $2.90B | $2.43B |
| Stock-Based Comp. | $0.00B | $0.01B | $0.04B | $0.00B | $0.06B |
| Change in Working Capital | ($0.65B) | ($0.37B) | ($5.11B) | $1.85B | $0.19B |
| Net Cash from Operations | ($5.76B) | ($6.61B) | ($8.75B) | ($11.21B) | ($11.38B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.01B) | ($0.08B) | ($0.09B) | ($0.02B) | ($0.08B) |
| Purchases of Investments | $0.00B | ($0.06B) | ($0.28B) | ($0.07B) | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | $0.02B | ($0.13B) | ($0.36B) | ($0.10B) | ($0.15B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | ($0.00B) | $0.00B | $0.00B | ($0.00B) |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | $1.30B | $0.00B | $0.00B | $0.00B |
| Net Cash from Financing | $5.91B | $4.20B | $2.04B | $3.57B | $17.38B |
| Free Cash Flow | |||||
| Free Cash Flow | ($5.77B) | ($6.69B) | ($8.84B) | ($11.23B) | ($11.46B) |
| FCF Margin %(computed) | -659.45% | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · JPY · B
深入了解AnGes, Inc.
关于AnGes, Inc.（AMGXF）现金流量表
AnGes, Inc. 2025财年经营活动现金流($5.76B)，自由现金流($5.77B)（FCF利润率-659.45%），资本支出($0.01B)。
常见问题
AMGXF · 4 问AnGes, Inc. 2025财年自由现金流($5.77B)，同比up13.8%。
AMGXF free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10